Fig 1.
HBoV-1 diagnostic findings in tracheal aspirate and serum. Day 1 is the starting day of ECMO treatment. Anti-HBoV-1 was not analyzed during or after ECMO treatment because of the heavy transfusion exposure associated with the procedure.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.